Telmisartan

Major

Telmisartan Lisinopril Prinivil Explained Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Relugolix Orgovyx Explained Increased relugolix exposure Details Telmisartan Alpelisib Piqray Increased alpelisib exposure and an increased risk of alpelisib-related adverse effects and toxicity Details Telmisartan Atogepant Qulipta Increased atogepant exposure Details Telmisartan Benazepril Lotensin Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Azilsartan Edarbi An increased risk of hyperkalemia, renal impairment and hypotension Details Telmisartan Captopril Capoten® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Cyclosporine Injection Atopica An increased risk of hyperkalemia and an increased cycloSPORINE exposure Details Telmisartan Cyclosporine Ophthalmic Cequa An increased risk of hyperkalemia and an increased cycloSPORINE exposure Details Telmisartan Dabigatran Pradaxa® Increased dabigatran exposure and an increased risk of bleeding Details Telmisartan Dabigatran Etexilate Increased dabigatran exposure and an increased risk of bleeding Details Telmisartan Digoxin Cardoxin® An increased digoxin exposure Details Telmisartan Doxorubicin Adriamycin Increased DOXOrubicin exposure and an increased risk of DOXOrubicin-related adverse reactions Details Telmisartan Enalapril Epaned Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Eprosartan Teveten® An increased risk of hyperkalemia, renal impairment and hypotension Details Telmisartan Fosinopril Monopril® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Furosemide Injection Disal Severe hypotension and deterioration in renal function, including renal failure Details Telmisartan Irbesartan Avapro An increased risk of hyperkalemia, renal impairment and hypotension Details Telmisartan Lefamulin Xenleta Increased lefamulin exposure and an increased risk of lefamulin-related adverse reactions Details Telmisartan Lithium Carbonate Lithobid Increased risk of lithium toxicity Details Telmisartan Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse effects Details Telmisartan Losartan Arbli An increased risk of hyperkalemia, renal impairment and hypotension Details Telmisartan Moexipril Univasc® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Telmisartan Morphine Injection Astramorph® PF Increased morphine exposure and an increased risk of morphine-related adverse effects (hypotension, respiratory depression, profou... Details Telmisartan Perindopril Aceon Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details